Breast cancer survivors are at lifetime risk for the development of breast cancer–related lymphedema, a chronic, potentially debilitating condition that requires life-long symptom management. Suboptimal self-management rates suggest that health care providers may not be offering educative-support options that are customized to patient-perceived needs. An Institutional Review Board–approved focus group (N = 9) and mailed surveys (N = 15) were used to identify (a) barriers to lymphedema self-management, (b) how breast cancer survivors with lymphedema defined education and support, (c) what type of education and support they had received, and (d) what kind of education and support they wanted. Physiological, psychological, and psychosocial factors were identified as barriers to successful lymphedema self-management. One of the main barriers identified was lack of education about lymphedema treatment and risk reduction. In addition, more than half defined support as “prescriptions” and “referrals”; therefore, it is unclear whether patients were exposed to support other than medical treatment.
AlcorsoJ.ShermanK. A.KoelmeyerL.MackieH.BoyagesJ. (2016). Psychosocial factors associated with adherence for self-management behaviors in women with breast cancer-related lymphedema. Supportive Care in Cancer, 24, 139-146.
ArmerJ. M.BrooksC. W.StewartB. R. (2011). Limitations of self-care in reducing the risk of lymphedema: Supportive-educative systems. Nursing Science Quarterly, 24, 57-63. doi:10.1177/0894318410389058
4.
ArmerJ. M.HenggelerM. H.BrooksC. W.ZagarE. A.HomanS.StewartB. R. (2008). The health deviation of post-breast cancer lymphedema: Symptom assessment and impact on self-care agency. Self-Care, Dependent-Care & Nursing, 16, 14-21.
5.
ArmerJ. M.HulettJ. M.BernasM.OstbyP.StewartB. R.CormierJ. N. (2013). Best-practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema. Current Breast Cancer Reports, 5, 134-144. doi:10.1007/s12609-013-0105-0
6.
ArmerJ. M.StewartB. R. (2010). Post-breast cancer lymphedema: Incidence increases from 12 to 30 to 60 months. Lymphology, 43, 118-127.
7.
BelluryL.EllingtonL.BeckS. L.PettM. A.ClarkJ.SteinK. (2013). Older breast cancer survivors: Can interaction analyses identify vulnerable subgroups? A report from the American cancer society studies of cancer survivors. Oncology Nursing Forum, 40, 325-336.
8.
BernasM. J.AskewR. L.ArmerJ. M.CormierJ. N. (2010). Lymphedema: How do we diagnose and reduce the risk of this dreaded complication of breast cancer treatment?Current Breast Cancer Reports, 2, 53-58. doi:10.1007/s12609-010-0009-1
9.
BlaiseS.SatgerB.PernodG.RichaudC.VillemurB.CarpentierP. H. (2017). Impact of an educational program on the quality of life of patients with lymphedema: A preliminary evaluation. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 5, 715-722. doi:10.1016/j.jvsv.2017.06.004
10.
BorisM.WeindorfS.LasinskiB. (1997). Persistence of lymphedema reduction after noninvasive complex lymphedema therapy. Oncology, 11, 99-109.
11.
BrownJ. C.ChevilleA. L.TchouJ. C.HarrisS. R.SchmitzK. H. (2014). Prescription and adherence to lymphedema self-care modalities among women with breast cancer-related lymphedema. Supportive Care in Cancer, 22, 135-143. doi:10.1007/s00520-013-1962-9
12.
BrownJ. C.KumarA.ChevilleA. L.TchouJ. C.TroxelA. B.HarrisS. R.SchmitzK. H. (2015). Association between lymphedema self-care adherence and lymphedema outcomes among women with breast cancer-related lymphedema. American Journal of Physical Medicine & Rehabilitation, 94, 288-296.
13.
CalA.BaharZ. (2016). Women’s barriers to prevention of lymphedema after breast surgery and home care needs: A qualitative study. Cancer Nursing, 39(6), 17-25. doi:10.1097/NCC.0000000000000326
14.
CorbinJ.StraussA. (2008). Basics of qualitative research: Techniques and procedures for developing grounded theory (3rd ed.). Thousand Oaks, CA: Sage.
15.
Dedoose Version 6.1.18. (2015). Web application for managing, analyzing, and presenting qualitative and mixed method research data. Los Angeles, CA: SocioCultural Research Consultants, LLC.www.dedoose.com.
16.
DengJ.FuM. R.ArmerJ. M.CormierJ. N.RadinaE.ThiadensS. R.. . . RidnerS. H. (2013). Self-reported information sources and perceived knowledge in individuals with lymphedema. Lymphology, 46, 173-183.
17.
DiSipioT.RyeS.NewmanB.HayesS. (2013). Incidence of unilateral arm lymphoedema after breast cancer: A systematic review and meta-analysis. The Lancet Oncology, 14, 500-515.
18.
DouglassJ.GravesP.GordonS. (2016). Self-care for management of secondary lymphedema: A systematic review. PLoS Neglected Tropical Diseases, 10(6), 1-20. doi:10.1371/journal.pntd.0004740
19.
FuM. R.ChenC. M.HaberJ.GuthA. A.AxelrodD. (2010). The effect of providing information about lymphedema on the cognitive and symptom outcomes of breast cancer survivors. Annals of Surgical Oncology, 17, 1847-1853. doi:10.1245/s10434-010-0941-3
20.
FuM. R.KangY. (2013). Psychosocial impact of living with cancer-related lymphedema. Seminars in Oncology Nursing, 29, 50-60. doi:10.1016/j.soncn.2012.11.007
21.
FuM. R.RidnerS. H.HuS. H.StewartB. R.CormierJ. N.ArmerJ. M. (2013). Psychosocial impact of lymphedema: A systematic review of literature from 2004 to2011. Psycho-Oncology, 22, 1466-1484. doi:10.1002/pon.3201
22.
GlaserB. G.StraussA. L. (1967). The discovery of grounded theory: Strategies for qualitative research. Piscataway, NJ: Transaction Publishers.
23.
HowladerN.NooneA. M.KrapchoM.MillerD.BishopK.KosaryC. L.. . . CroninK. A. (Eds.). (2017). SEER Cancer Statistics Review, 1975–2014. Bethesda, MD: National Cancer Institute. Retrieved from https://seer.cancer.gov/csr/1975_2014/
24.
International Society of Lymphology. (2016). The diagnosis and treatment of peripheral lymphedema: 2016 Consensus document of the International Society of Lymphology. Lymphology, 49, 170-184.
25.
KwanM. L.ShenL.MunnekeJ. R.TamE. K.ParteeP. N.AndréM.. . . ThiadensS. R. J. (2012). Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system. Breast Cancer Research and Treatment, 135, 591-602. doi:10.1007/s10549-012-2199-x
26.
LasinskiB. B. (2013). Complete decongestive therapy for treatment of lymphedema. Seminars in Oncology Nursing, 29, 20-27. doi:10.1016/j.soncn.2012.11.004
27.
LasinskiB. B.McKillip ThriftK.SquireD.AustinM. K.SmithK. M.WanchaiA.. . . ArmerJ. M. (2012). A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. PM&R, 4, 580-601. doi:10.1016/j.pmrj.2012.05.003
28.
LeeT. S.KilbreathS. L.SullivanG.RefshaugeK. M.BeithJ. M. (2010). Patient perceptions of arm care and exercise advice after breast cancer surgery. Oncology Nursing Forum, 37, 85-91. doi:10.1188/10.ONF.85-91
29.
LeventhalH.LeventhalE. A.BrelandJ. Y. (2011). Cognitive science speaks to the “common-sense” of chronic illness management. Annals of Behavioral Medicine, 41, 152-163. doi:10.1007/s12160-010-9246-9
30.
LeventhalH.PhillipsL. A.BurnsE. (2016). The Common-Sense Model of Self-Regulation (CSM): A dynamic framework for understanding illness self-management. Journal of Behavioral Medicine, 39, 935-946.
31.
McLaughlinS. A.StaleyA. C.ViciniF.ThiruchelvamP.HutchisonN. A.MendezJ.. . . FeldmanS. M. (2017). Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema: Recommendations from a multidisciplinary expert ASBrS panel. Annals of Surgical Oncology, 24, 2818-2826.
32.
MillerC. L.SpechtM. C.SkolnyM. N.HorickN.JammalloL. S.O’TooleJ.. . . TaghianA. G. (2014). Risk of lymphedema after mastectomy: Potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients. Breast Cancer Research and Treatment, 144, 71-77.
OstbyP. L.ArmerJ. M. (2015). Complexities of adherence and post-cancer lymphedema management. Journal of Personalized Medicine, 5, 370-388. doi:10.3390/jpm5040370
35.
OstbyP. L.ArmerJ. M.DaleP. S.Van LooM. J.WilbanksC. L.StewartB. R. (2014). Surveillance recommendations in reducing risk of and optimally managing breast cancer-related lymphedema. Journal of Personalized Medicine, 4, 424-447. doi:10.3390/jpm4030424
36.
RichardsL.MorseJ. M. (2013). Making data. In KnightV.GrangerM. (Eds.), Readme first for a user’s guide to qualitative methods (3rd ed., pp. 119-147). Los Angeles, CA: Sage.
37.
RidnerS. H.DietrichM. S. (2008). Self-reported comorbid conditions and medication usage in breast cancer survivors with and without lymphedema. Oncology Nursing Forum, 35, 57-63.
38.
RidnerS. H.DietrichM. S.KiddN. (2011). Breast cancer treatment-related lymphedema self-care: Education, practices, symptoms, and quality of life. Supportive Care in Cancer, 19, 631-637. doi:10.1007/s00520-010-0870-5
39.
RidnerS. H.FuM. R.WanchaiA.StewartB. R.ArmerJ. M.CormierJ. N. (2012). Self-management of lymphedema: A systematic review of the literature from 2004 to 2011. Nursing Research, 61, 291-299.
40.
RidnerS. H.RhotenB. A.RadinaM. E.AdairM.Bush-FosterS.SinclairV. (2016). Breast cancer survivors’ perspectives of critical lymphedema self-care support needs. Supportive Care in Cancer, 24, 2743-2750. doi:10.1007/s00520-016-3089-2
41.
RosedaleM.FuM. R. (2010). Confronting the unexpected: Temporal, situational, and attributive dimensions of distressing symptom experience for breast cancer survivors. Oncology Nursing Forum, 37, E28-E33. doi:10.1188/10.ONF.E28-E33
42.
ShermanK. A.KoelmeyerL. (2013). Psychosocial predictors of adherence to lymphedema risk minimization guidelines among women with breast cancer. Psycho-Oncology, 22, 1120-1126. doi:10.1002/pon.3111
43.
ShermanK. A.MillerS. M.RoussiP.TaylorA. (2015). Factors predicting adherence to risk management behaviors of women at increased risk for developing lymphedema. Supportive Care in Cancer, 23, 61-69. doi:10.1007/s00520-014-2321-1
44.
StuiverM. M.Ten TusscherM. R.McNeelyM. L. (2017). Which are the best conservative interventions for lymphoedema after breast cancer surgery?British Medical Journal, 357, Article j2330.
45.
TamE. K.ShenL.MunnekeJ. R.AckersonL. M.ParteeP. N.SomkinC. P.. . . KwanM. L. (2012). Clinician awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery setting. Breast Cancer Research and Treatment, 131, 1029-1038. doi:10.1007/s10549-011-1829-z
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
